In line with previous findings, we observed a significant upregulation of HANR in CRC tumors relative to adjacent normal controls, with ROC curve analyses confirming that HANR may be an effective marker well-suited to differentiating between normal and tumor tissue. This evidence concerns the gene RPL13AP20 and colorectal carcinoma.